Emitents | Olainfarm, AS (213800WCG52W62ENOP27) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Veids | Citi | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Valoda | EN | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Statuss | Publicēts | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Versija | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Datums | 2016-02-14 22:25:44 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Versijas komentārs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Teksts |
Olaine, 2016.gada 15.februārī
Olainfarm
Starts 2016 With 14% Sales Growth
According to
preliminary consolidated sales figures of AS Olainfarm for January
2016, the sales have reached 8.84 million euro, which represents an
increase by 14% compared to the same period of last year. The
major sales increase was achieved in Belarus, where sales grew by
1001%. Sales to Turkmenistan grew by 674%, sales to
Kazakhstan grew by 286%, while sales to Italy grew by 257%.
During January 2016, significant shipments have also been
made to Poland and Germany. The major sales markets during
January 2016 were Russia, Belarus, UK and Ukraine.
Sales of pharmacy
chain of SIA Latvijas aptieka during January 2016 were 1.66 million
EUR, which represents an increase by 16% compared to the same
period of 2015. 62 pharmacies were operating during January.
Sales of SIA Silvanols during January 2016 were 0.32 million euros,
which represents a reduction by 18% compared to January 2015.
During January 2016 SIA Silvanols sold its products to six European
countries, and with mediation of AS Olainfarm also to Kazakhstan
and Belarus.
According to
preliminary unconsolidated results, sales of AS Olainfarm in
January 2016 were 7.76 million euros, which represents an increase
by 19% compared to the same period one year ago. The biggest
sales increase was achieved in Belarus, where sales gre by
1001%. Sales to Turkmenistan grew by 674%, sales to
Kazakhstan grew by 286%, but sales to Italy grew by 257%.
During January 2016, significant shipments were also made to Poland
and Germany. The Major sales markets of AS Olainfarm during this
period were Russia, Belarus, Latvia, UK and Ukraine. During January
of 2016, products of AS Olainfarm were sold to 21 countries in
Europe and Asia.
According to
preliminary estimates of AS Olainfarm, unconsolidated sales of the
company in 2016 will reach 90 million euros, while consolidated
sales will reach 103 million euros. According to these preliminary
sales figures, during January 2016 the company has attained 9% of
its annual target for unconsolidated sales and 9% of its annual
target for consolidated sales. JSC Olainfarm is one of the
biggest pharmaceutical companies in Latvia with more than 40 years
of experience in production of medication and chemical and
pharmaceutical products. A basic principle of company's operations
is to produce reliable and effective top quality products for
Latvia and the rest of the world. Products made by the Group are
being exported to more than 35 countries of the world, including
the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia. Information
prepared by:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pielikumi |
|